ストックスクリーナーアプリを入手
2.635
6.05%
0.155
前日終値:
$2.48
開ける：
$2.48
24時間の取引高:
972.64K
Relative Volume:
0.29
時価総額：
$139.88M
収益：
-
当期純損益:
$-82.44M
株価収益率:
-1.4016
EPS:
-1.88
ネットキャッシュフロー:
$-66.75M
1週間 パフォーマンス:
+1.54%
1か月 パフォーマンス:
+10.97%
6か月 パフォーマンス:
+22.90%
1年 パフォーマンス:
-37.53%
1日の値動き範囲:
$2.43
$2.715
1週間の範囲:
$2.34
$2.715
52週間の値動き範囲:
$1.195
$6.75
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
名前
Black Diamond Therapeutics Inc
セクター
電話
617-417-5868
住所
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.635 | 139.88M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.17 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
548.79 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.13 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.67 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
243.95 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-31 | 開始されました | Raymond James | Outperform |
| 2023-07-14 | 開始されました | Piper Sandler | Overweight |
| 2023-06-30 | アップグレード | Stifel | Hold → Buy |
| 2023-06-28 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-03-29 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-03-22 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | 開始されました | Stifel | Hold |
| 2021-01-07 | 開始されました | Wedbush | Outperform |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2020-02-24 | 開始されました | Canaccord Genuity | Buy |
| 2020-02-24 | 開始されました | Cowen | Outperform |
| 2020-02-24 | 開始されました | JP Morgan | Overweight |
| 2020-02-24 | 開始されました | Jefferies | Buy |
すべてを表示
Black Diamond Therapeutics Inc (BDTX) 最新ニュース
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Holdings Boosted by Bank of America Corp DE - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Rating of “Buy” from Analysts - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street Zen - Defense World
Black Diamond’s 2025 Annual Stockholders Meeting Highlights - TipRanks
Black Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant Upside - Seeking Alpha
Wellington Management Group LLP Grows Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Squarepoint Ops LLC Buys 72,688 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Downgraded to Hold Rating by Wall Street Zen - Defense World
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Nuveen Asset Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Northern Trust Corp - Defense World
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewswire
17,317 Shares in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Bought by D. E. Shaw & Co. Inc. - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) & Fresh Tracks Therapeutics (NASDAQ:FRTX) Critical Comparison - Defense World
Brokerages Set Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Price Target at $14.60 - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Raised to Buy at Wall Street Zen - Defense World
Black Diamond Therapeutics Reports Strong Q1 2025 Earnings - TipRanks
3 Promising Penny Stocks With Market Caps Under $200M - Yahoo Finance
Price T Rowe Associates Inc. MD Cuts Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Wedbush Issues Optimistic Estimate for BDTX Earnings - Defense World
Dimensional Fund Advisors LP Has $1.42 Million Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Raymond James Financial Inc. Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Stifel Financial Corp Raises Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Wells Fargo & Company MN Buys 5,932 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Inc (BDTX) Q1 2025 Earnings: Net Inco - GuruFocus
Black Diamond (BDTX) Strengthens Financial Position with Robust Cash Reserves | BDTX Stock News - GuruFocus
Black Diamond Therapeutics (BDTX) Surpasses Q1 Earnings Expectat - GuruFocus
What You Didn’t Know About Black Diamond Therapeutics Inc (NASDAQ: BDTX) This Week - Stocksregister
Hsbc Holdings PLC Has $59,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Barclays PLC Increases Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Reports Q1 2025 Financial Results and Updates on Clinical Trials for BDTX-1535 - Nasdaq
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Skill-Knowledge-Conduct - TradingView
JPMorgan Chase & Co. Has $41,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Market Momentum: Black Diamond Therapeutics Inc (BDTX) Registers a -12.28 Decrease, Closing at 1.47 - DWinneX
BlackRock, Inc. Reduces Stake in Black Diamond Therapeutics Inc - GuruFocus
Black Diamond Therapeutics Inc expected to post earnings of 20 cents a shareEarnings Preview - TradingView
Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year - Yahoo Finance
A History of Outperforming Analyst Forecasts and Beating the Odds: Black Diamond Therapeutics Inc (BDTX) - Sete News
Black Diamond Therapeutics Inc (BDTX) stock analysis: A comprehensive overview - uspostnews.com
Black Diamond Therapeutics Inc’s Banking’s 100-Day Moving Average at 2.0161: Will the Stock Break Through? - investchronicle.com
Geode Capital Management LLC Has $2.05 Million Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Financial Metrics Exploration: Understanding Black Diamond Therapeutics Inc (BDTX) Through Ratios - DWinneX
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Bought by Renaissance Technologies LLC - The AM Reporter
Black Diamond Therapeutics Inc (BDTX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Head-To-Head Contrast: Avalon GloboCare (NASDAQ:ALBT) and Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Wellington Management Group LLP - Defense World
Raymond James Financial Inc. Purchases New Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Sei Investments Co. Purchases Shares of 22,802 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX Stock Sees Decline of Approximately -12.66% in Last Five Days - knoxdaily.com
Black Diamond Therapeutics Inc (BDTX) 財務データ
収益
当期純利益
現金流量
EPS
Black Diamond Therapeutics Inc (BDTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Aug 28 '24 |
Sale |
6.32 |
221,600 |
1,400,556 |
3,726,341 |
0.75%
0.43%
大文字化:
|
ボリューム (24 時間):